Parkinson’s disease is a neurological disorder that can be treated by modulating the activity of D2R and A2AR. However, the identification of dual-target ligands of A2AR and D2R is challenging because of the lack of similarity between the binding sites of the receptors35. This evidence concerns the gene ADORA2A and nervous system disorder.